RSS

CVM Cel-Sci Corp.

Mod: mick
Last Post: 11/06/23
Followers: 1
Posts Today: 0
Views Today: 47

CVM Stock Quote & Tools

$1.7100 ▼ -0.0400 (-2.29%) As of Oct 14, 10:26 AM EDT
Last1.7100
$ Chg-0.0400
Open1.7300
High1.7500
Beta0.5886
Year High10.240
Market Cap30.08M
P/B Ratio3.11
EPS-1.03
Avg Vol (30d)234.7K
Volume16.2K
% Chg-2.29%
Prev Close1.7500
Low1.6800
VWAP1.70624
Year Low0.890
Total Shares17.59M
Shares Out17.59M
Float16.77M
ExchangeNYSE American
Healthcare Biotechnology & Life Sciences

CVM Stock Message Board Discussion

  1. mick

Top 10 Most Recent News Articles

Detroit Hosts Groundbreaking AquaHacking Challenge

Updated Category News Views 194

Shaking Up the Water Scene in Detroit Forget Wall Street for a moment—there's a new kind of trading floor where the stakes are nothing less than the health of our waterways. Yesterday, Detroit saw the Great Lakes and St. Lawrence Binational AquaHacking Challenge 2026 wrap up with a bang, having gathered 12 fiery teams on a mission to tackle urgent water issues head-on....

Continue Reading
U Power's H1 2026: Inside the Financial Numbers

Updated Category News Views 137

Financial Struggles Amid Expansion Efforts Imagine a ship trying to lift anchor while taking on water. That's U Power Limited's latest financials for the first half of 2026 in a nutshell. We're seeing the company, listed under NASDAQ: UCAR, navigating through turbulent financial seas while executing ambitious expansion projects. Revenue Declines Spell Trouble Total net...

Continue Reading
Everest Group Faces Major Class Action Deadline Looms

Updated Category News Views 166

Everest Group's Headaches Multiply as Deadline Approaches Well, here we find a classic case of Wall Street drama—Everest Group, Ltd. (NYSE:EG), a company whose troubles would make any trader weary. As of late, it's caught up in a nasty class-action lawsuit with stakes high enough to raise eyebrows from Broadway to Bayou. Investors in Everest better be tuned in, because...

Continue Reading
DraftKings Faces Revenue Cutback; Legal Probe Begins

Updated Category News Views 144

DraftKings' Surprising Turn of Fortune Talk about a gut punch! DraftKings (NASDAQ: DKNG) dropped a bombshell that had investors reeling. They decided to lop off a hefty slice of their revenue guidance, and trust me, those aren't small numbers we’re talking about. On November 6, they yanked their full-year 2026 revenue guidance down to $6.35 billion to $6.55 billion from...

Continue Reading
Cognizant Grabs Wizeline: A Power Play in Digital

Updated Category News Views 189

An Acquisition with Strategic Weight Cognizant's just bagged a beast, folks. The purchase of Wizeline marks a hefty step for NASDAQ:CTSH in the ever-evolving landscape of digital engineering and AI. It's not the kind of strategic move you see every day. The Wizeline Asset: What Stands Out? Wizeline isn't just window dressing. It's a heavy hitter in AI-native digital...

Continue Reading
Muyuan Foods Spotlights Smart Farming at EuroTier 2026

Updated Category News Views 120

Muyuan Foods Ready to Impress at EuroTier 2026 Let's face it, folks—when you think of game-changers in pig farming, Muyuan Foods Group deserves a nod. They're not just trotting out oinkers left and right; they're steering the whole paddock with innovations in smart pig farming and green development solutions. At EuroTier 2026 in Hanover, Muyuan’s booth—J04 in Hall...

Continue Reading
Tenax Therapeutics Faces Legal Heat After Stock Plunge

Updated Category News Views 125

Investors' Nerves Tested as Tenax Takes a Nosedive Holy smokes! When a biotech company like Tenax Therapeutics, Inc. (NASDAQ: TENX) detonates like a forgotten fireworks stash, investors have every right to get itchy. Tenax’s shocking announcement that their Phase 3 LEVEL trial for TNX-103 flopped has sparked more than just shareholder anxiety. It’s ignited a...

Continue Reading
Kestrel Group Faces Financial Hit Despite Revenue Growth

Updated Category News Views 169

Kestrel's Financial Rollercoaster Continues Here's the deal with Kestrel Group, folks. They just dropped their Q3 2026 financials, and it's a mixed bag. The top line's looking solid with total revenues hitting $4.8 million, riding high on a 203% jump in Program Services fee income. But dig a little deeper, and there's a $16.4 million net loss staring us in the face....

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 170

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 77

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Booming Cold Chain RFID Market Growth Trends

Updated Category News Views 243

Overview of the Cold Chain RFID Market The Cold Chain RFID Market is on the verge of significant expansion, with forecasts suggesting it could reach an estimated USD 4636.6 million by 2030. This growth is fueled by the increasing demand for efficient tracking and monitoring solutions for temperature-sensitive products. Segment Breakdown of Cold Chain RFID Technology This...

Continue Reading
FRC Welcomes Christopher Lynch to Its Board for Growth Strategies

Updated Category News Views 161

FRC Welcomes Christopher Lynch to Strengthen Board Leadership FRC is thrilled to announce the addition of Christopher Lynch to its Board of Directors. This appointment marks a significant step in enhancing the strategic leadership and governance needed for the company's ongoing growth. Lynch joins Executive Chairman Alan Marc Smith, helping to pave the way for FRC’s...

Continue Reading
Breakthrough Study Shows BioProtect Balloon Spacer's Efficacy

Updated Category News Views 213

BioProtect Ltd., the MedTech firm shaking up cancer care, rolled out some jaw-dropping findings from its pivotal clinical study back in 2024. The study, published in a top-tier international journal, focused on their BioProtect Balloon spacer designed to shield the rectum during prostate cancer radiation therapy. Traders got wind of this and began eyeing the stock as the...

Continue Reading
Horizon Bancorp Announces $0.16 Dividend for Shareholders

Updated Category News Views 92

Horizon Bancorp's Dividend Announcement Horizon Bancorp Inc. (NASDAQ: HBNC) has just announced a quarterly dividend of $0.16 per share for its stockholders. Based in Michigan City, this state commercial bank emphasizes its commitment to delivering returns to investors. Shareholders can expect the dividend to be paid after the record date, highlighting the bank's efforts...

Continue Reading
Tesla's Ambitious AI and Robotaxi Plans Could Boost Valuation

Updated Category News Views 284

Tesla's Innovative Future: AI and Robotaxi Development Tesla (NASDAQ: TSLA) is stepping into a significant era under the leadership of its CEO, Elon Musk, where artificial intelligence and robotaxi services are set to revolutionize its growth trajectory. Positioning for Success in the Autonomous Vehicle Market Industry experts believe that Tesla is on the verge of leading...

Continue Reading